Drivers of cancer: Oncogenes and Tumor suppressor genes

Cancer is a complex and devastating group of diseases characterized by uncontrolled cell growth and proliferation. Understanding the molecular drivers behind cancer is crucial in the quest for effective treatments and prevention. Among the central players in this intricate scenario are oncogenes and tumor suppressor genes.

Oncogenes: The Accelerators of Cancer

Oncogenes are genes that promote cell growth and division when they are mutated or activated. Their normal counterparts, known as proto-oncogenes, play essential roles in regulating cell growth and tissue repair. However, when proto-oncogenes undergo mutations or become abnormally activated, they transform into oncogenes, which drive uncontrolled cell proliferation and contribute to the development of cancer.

Mechanisms of Oncogene Activation

There are several mechanisms through which oncogenes can become activated:

1. Point Mutations: A common mechanism involves point mutations in the DNA sequence of proto-oncogenes. These mutations can lead to the constitutive activation of the gene, causing it to be "stuck" in the "on" position.

2. Gene Amplification: In some cases, proto-oncogenes can become amplified, resulting in an increased number of gene copies. This amplification leads to an overproduction of the protein the gene encodes, driving abnormal cell growth.

3. Chromosomal Translocations: Translocations occur when a segment of one chromosome becomes fused with another chromosome. This fusion event can result in the activation of oncogenes. The BCR-ABL fusion gene, seen in chronic myeloid leukaemia (CML), is a notable example of an oncogenic fusion event.

Common Oncogenes

• Ras mutations in lung, pancreatic, and colorectal cancer
• HER2 in breast cancer
• BRAF in melanoma

https://www.shutterstock.com/image-vector/proto-oncogene-versus-vector-illustration-diagram-2175580205

Tumor Suppressor Genes: The Brakes of Cancer

Tumor suppressor genes, in contrast to oncogenes, function to regulate cell growth and prevent the development of cancer. When these genes are mutated or inactivated, they lose their ability to inhibit cell division, allowing for uncontrolled proliferation and the initiation of tumorigenesis.

Mechanisms of Tumor Suppressor Gene Inactivation

Tumor suppressor genes can be inactivated through several mechanisms:

1. Deletion or Mutation: The loss of one or both copies of a tumor suppressor gene, often through chromosomal deletions or mutations, can render the gene nonfunctional. This loss of function eliminates the gene's ability to control cell growth.

2. Epigenetic Silencing: Tumor suppressor genes can be silenced by epigenetic modifications, such as DNA methylation and histone deacetylation. These modifications prevent the transcription of the gene, effectively turning it off.

3. Protein Degradation: Some tumor suppressor proteins are targeted for degradation by the cell's protein quality control system. When these proteins are removed, the brakes on cell growth are released.

Notable Tumor Suppressor Genes

• p53 inactivated in lung, breast, and colorectal cancer
• BRCA1 and BRCA2 inactivated in breast and ovarian cancer
• APC mutations in colorectal cancer

https://cisncancer.org/research/images/nci_s51_genomics-rew.jpg

Interplay Between Oncogenes and Tumor Suppressor Genes

The development of cancer is often driven by a combination of oncogene activation and tumor suppressor gene inactivation. The loss of tumor suppressor function removes the natural controls that inhibit cell growth, while the activation of oncogenes provides the stimulus for uncontrolled proliferation.

For example, in colorectal cancer, mutations in the APC gene (a tumor suppressor) lead to uncontrolled cell division. Additionally, activating mutations in the KRAS gene (an oncogene) stimulate cell growth. The combination of APC inactivation and KRAS activation contributes to the progression of colorectal cancer.

Conclusion

Oncogenes and tumor suppressor genes are the central players in the intricate world of cancer biology. Their roles in promoting or inhibiting cell growth are essential for understanding the molecular basis of cancer development. As we continue to unravel the genetic and molecular complexities of cancer, targeted therapies and innovative treatments hold the potential to provide more effective strategies for cancer management and prevention.

MD: Understanding the drivers of cancer and their interdependence that leads to a deadly disease called Cancer.